{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:18:13Z","timestamp":1791289093048,"version":"4.3.0"},"reference-count":42,"publisher":"Wiley","issue":"13","license":[{"start":{"date-parts":[[2005,8,25]],"date-time":"2005-08-25T00:00:00Z","timestamp":1124928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP 62837"],"award-info":[{"award-number":["MOP 62837"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    CD36, a type B scavenger receptor expressed on macrophages, appears to play a major role in fatty streak formation through scavenging oxidatively modified lipoproteins in the arterial wall. We tested the hypothesis that EP 80317, a novel CD36 ligand derived from the growth hormone (GH)\u2010releasing peptide family but devoided of any GH releasing activity, exerts anti\u2010atherosclerotic effects in apolipoprotein E\u2010deficient (apoE\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    ) mice fed an atherogenic diet from 6 wk of age. Daily subcutaneous injections of EP 80317 (300 \u00b5g\/kg) or vehicle were initiated at 6, 10, 12, or 14 wk until death at 18 wk. En face analyses of the entire aortic tree revealed a striking reduction (up to 51%) of lesion areas in EP 80317\u2010treated apoE\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice compared with controls. Chronic treatment with EP 80317 (12 wk) is also associated with a 30% decrease in total plasma cholesterol, suggesting potential effects of this drug on cholesterol metabolism at the intestine\/hepatic levels. EP 80317 exerts both preventive and curative effects on atherosclerotic lesion progression that were shown to be reversible after cessation of treatment. At the macrophage level, EP 80317 reduced oxidized low density lipoproteins internalization and up\u2010regulated genes involved in cholesterol efflux, including peroxisome proliferator\u2010activated receptor \u03b3 (PPAR\u03b3), liver x receptor \u03b1 (LXR\u03b1), and the ATP binding cassette (ABC) transporters ABCA1 and ABCG1, supporting a role in regulating peripheral cholesterol trafficking. Importantly, the effects of EP 80317 were shown to be CD36 dependent, inasmuch as no anti\u2010atherosclerotic or hypocholesterolemic effects were observed in apoE\/CD36 double\u2010deficient mice. In addition, long\u2010term treatment of apoE\/CD36 double\u2010deficient mice with EP 80317 did not modulate the expression of genes of the PPAR\u03b3\u2010LXR\u03b1\u2010ABC transporters pathway. Our results suggest that EP 80317, as a CD36 ligand, might be a prototype for a novel class of anti\u2010atherosclerotic agents.\n                  <\/jats:p>","DOI":"10.1096\/fj.04-3253fje","type":"journal-article","created":{"date-parts":[[2005,8,25]],"date-time":"2005-08-25T20:33:35Z","timestamp":1125002015000},"page":"1869-1871","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E\u2010deficient mice from developing atherosclerotic lesions"],"prefix":"10.1096","volume":"19","author":[{"given":"Sylvie","family":"Marleau","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy Department of Pharmacology Faculty of Medicine Universit\u00e9 de Montr\u00e9al  Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diala","family":"Harb","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy Department of Pharmacology Faculty of Medicine Universit\u00e9 de Montr\u00e9al  Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Bujold","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy Department of Pharmacology Faculty of Medicine Universit\u00e9 de Montr\u00e9al  Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Avallone","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy Department of Pharmacology Faculty of Medicine Universit\u00e9 de Montr\u00e9al  Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Iken","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy Department of Pharmacology Faculty of Medicine Universit\u00e9 de Montr\u00e9al  Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Wang","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy Department of Pharmacology Faculty of Medicine Universit\u00e9 de Montr\u00e9al  Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Demers","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy Department of Pharmacology Faculty of Medicine Universit\u00e9 de Montr\u00e9al  Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Sirois","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Faculty of Medicine Universit\u00e9 de Montr\u00e9al  Qu\u00e9bec Canada"},{"name":"Montreal Heart Institute  Montr\u00e9al Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Febbraio","sequence":"additional","affiliation":[{"name":"Department of Cell Biology Lerner Research Institute Cleveland Clinic Foundation  Cleveland Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy L.","family":"Silverstein","sequence":"additional","affiliation":[{"name":"Department of Cell Biology Lerner Research Institute Cleveland Clinic Foundation  Cleveland Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Tremblay","sequence":"additional","affiliation":[{"name":"Department of Obstetrics &amp; Gynecology and Biochemistry Faculty of Medicine Universit\u00e9 de Montr\u00e9al  Qu\u00e9bec Canada"},{"name":"Ste\u2010Justine Hospital Research Center  Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy","family":"Ong","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy Department of Pharmacology Faculty of Medicine Universit\u00e9 de Montr\u00e9al  Qu\u00e9bec Canada"},{"name":"Department of Pharmacology Faculty of Medicine Universit\u00e9 de Montr\u00e9al  Qu\u00e9bec Canada"},{"name":"Montreal Heart Institute  Montr\u00e9al Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,8,25]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/35025203"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1102-1211"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-001-0318-y"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-2275(20)30159-0","article-title":"PPARadigms and PPARadoxes: expanding roles for PPAR\u03b3 in the control of lipid metabolism","volume":"43","author":"Walczack R.","year":"2002","journal-title":"J. Lipid Res."},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1102-1243"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI9259"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI14006"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890310008198"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M200685200"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2003.10.016"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(01)00164-2"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/83348"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.289.5484.1524"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.04689.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0403506101"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000016164.02525.B4"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s000180050257"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1006\/phrs.1997.0253","article-title":"Growth hormone secretagogues: focus on the growth hormone\u2010releasing peptides","volume":"36","author":"Locatelli V.","year":"1997","journal-title":"Pharmacol. Res."},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:14:1:087"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.85.9.796"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01178-3"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01475-3"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03343555"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.140.9.4024"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199808000-00013"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.141.1.60"},{"key":"e_1_2_6_28_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-044482933-7\/50053-6","volume-title":"Growth Hormone Secretagogues","author":"Berti F.","year":"1999"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-221048"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1982.tb31230.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0022-2275(20)38334-6","article-title":"Sodium dodecyl sulfate\u2010glycerol polyacrylamide slab gel electrophoresis for the resolution of apolipoproteins","volume":"30","author":"Maguire G. F.","year":"1989","journal-title":"J. Lipid Res."},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.18.5.794"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)32389-0"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.27.19055"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1102-1235"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209649200"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.5.1333"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20040036"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.14.1.133"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.112059299"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.182199799"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1210\/me.2003-0061"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M204887200"}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.04-3253fje","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fj.04-3253fje","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.04-3253fje","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:58:23Z","timestamp":1761670703000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.04-3253fje"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,25]]},"references-count":42,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1096\/fj.04-3253fje"],"URL":"https:\/\/doi.org\/10.1096\/fj.04-3253fje","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,25]]},"assertion":[{"value":"2005-02-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-07-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-08-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}